Free Trial

Avanza Fonder AB Buys New Holdings in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Avanza Fonder AB acquired a new stake in Xylem Inc. (NYSE:XYL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 22,694 shares of the industrial products company's stock, valued at approximately $2,633,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Swedbank AB boosted its stake in shares of Xylem by 22.8% in the third quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company's stock valued at $403,953,000 after buying an additional 554,609 shares during the period. Erste Asset Management GmbH bought a new stake in shares of Xylem during the 3rd quarter valued at $68,593,000. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of Xylem during the 3rd quarter worth $52,169,000. Champlain Investment Partners LLC increased its position in shares of Xylem by 17.8% in the third quarter. Champlain Investment Partners LLC now owns 1,657,785 shares of the industrial products company's stock worth $223,851,000 after purchasing an additional 249,975 shares during the period. Finally, State Street Corp lifted its position in Xylem by 1.9% during the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company's stock worth $1,394,792,000 after purchasing an additional 189,820 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Trading Up 0.7 %

Xylem stock traded up $0.89 during mid-day trading on Friday, hitting $119.84. 1,396,460 shares of the stock were exchanged, compared to its average volume of 1,010,634. The firm's fifty day simple moving average is $121.08 and its two-hundred day simple moving average is $128.82. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 12 month low of $109.70 and a 12 month high of $146.08. The stock has a market capitalization of $29.11 billion, a price-to-earnings ratio of 35.04, a PEG ratio of 1.89 and a beta of 1.06.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, meeting analysts' consensus estimates of $1.11. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The business had revenue of $2.10 billion for the quarter, compared to analysts' expectations of $2.17 billion. During the same quarter in the prior year, the firm posted $0.99 earnings per share. The business's quarterly revenue was up .2% compared to the same quarter last year. Analysts forecast that Xylem Inc. will post 4.23 EPS for the current year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th were given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 1.20%. The ex-dividend date was Tuesday, November 26th. Xylem's dividend payout ratio (DPR) is 42.11%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on XYL shares. Robert W. Baird dropped their target price on shares of Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. TD Cowen reduced their target price on Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a report on Wednesday, November 6th. Royal Bank of Canada lowered their price target on Xylem from $163.00 to $162.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Citigroup decreased their target price on Xylem from $148.00 to $147.00 and set a "buy" rating on the stock in a research report on Monday, January 13th. Finally, Wolfe Research restated a "peer perform" rating on shares of Xylem in a research note on Thursday, December 12th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $152.10.

Get Our Latest Stock Analysis on Xylem

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines